Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
The incretin effect in critically ill patients: a case-control study
Signe Tellerup Nielsen, Susanne Janum,
Rikke Krogh-Madsen
, Thomas P Solomon,
Kirsten Møller
Department of Clinical Medicine
Inflammation, Metabolism and Oxidation
14
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The incretin effect in critically ill patients: a case-control study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Critically Ill Patients
100%
Incretin Effect
100%
Intravenous Glucose
71%
Oral Glucose Tolerance Test
71%
Glucagon-like
57%
Insulin Response
42%
Type 2 Diabetic Patients
42%
Glucose-dependent Insulinotropic Polypeptide
42%
Glucose Infusion
42%
Blood Glucose
42%
Control Subjects
42%
Glucagon
28%
Hyperglycemia
28%
Without Diabetes
28%
Intensive Care Unit
28%
Inflammatory Cytokines
28%
Glucose Administration
28%
C-peptide Levels
14%
Tumor Necrosis Factor-α
14%
Student's T-test
14%
Repeated Measurements
14%
Systemic Inflammation
14%
Group Level
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Healthy Controls
14%
Interleukin-6
14%
Trial Registration
14%
Phenotypical
14%
Insulin Secretion
14%
Beneficial Effects
14%
Serum Insulin
14%
Critical Illness
14%
Between-group
14%
Glycaemia
14%
Mixed Models
14%
Insulin Resistance
14%
Glucose Profile
14%
Oral Glucose
14%
C-peptide
14%
Plasma Parameters
14%
Incretin Hormones
14%
Body Mass Index
14%
Relative Difference
14%
Nursing and Health Professions
Incretin
100%
Case-Control Study
100%
Oral Glucose Tolerance Test
62%
Glucagon Like Peptide 1
50%
Glucose Blood Level
50%
Glucose Infusion
37%
Patient with Type 2 Diabetes
37%
Gastric Inhibitory Polypeptide
37%
Glucose Intake
25%
Intensive Care Unit
25%
Hyperglycemia
25%
Glucagon
25%
Interleukin 6
12%
Tumor Necrosis
12%
C Peptide
12%
Body Mass
12%
Insulin Resistance
12%
Inflammation
12%
Insulin Blood Level
12%
Non Insulin Dependent Diabetes Mellitus
12%
Critical Illness
12%
Blood Level
12%
Student T Test
12%